dcc-3116
deciphera
['agent', 'dcc-3116', 'deciphera', 'bridge bio']
bcbn feed: deciphera pharmaceuticals, inc. presents initial phase 1 single agent dose escalation data for first-in-class ulk inhibitor of autophagy, dcc-3116, at the european society for medical oncology ... #boston #biotech 
Boston Cambridge Biotech Networks: Building a community and providing news and events for the local life science industry. For jobs follow @bcbnjobs